Article Details
Retrieved on: 2023-09-15 13:32:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibody. In the first-in-human, dose-escalation study, the recommended phase 2 dose for teclistamab was established as a subcutaneous ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here